About Karl Schmidt
Karl Schmidt is chief operating officer of Sentonix, a Massachusetts biotech developing small-molecule drugs for Parkinson's, Alzheimer's and other neurodegenerative diseases. In January 2026 Sentonix signed a global strategic collaboration with Mabwell, a drug maker listed in Shanghai.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Karl Schmidt in the role, so the role may have started earlier or lasted longer.
Sentonix, Inc. Current
Chief Operating Officer
2024 – Present · Arlington, MA
Biotech company developing precision treatments for neurodegenerative diseases
Key Colleagues at Startups
The people Karl Schmidt works with at each company, as listed on that company's latest Form D.
Sentonix, Inc. · Form D, Aug 20, 2026
Kenan Turnacioglu
Executive officer and director
JB
John Beaver
Chief Executive Officer and director
Jack Hoppin
Director